Pharmaceutical

STAT+: Pharmalittle: Appeals court rules Purdue can shi...

A U.S. appeals court ruled that Purdue Pharma can shield its owners from lawsuit...

Opinion: Newly diagnosed cancer patients need help navi...

So you have cancer. Now what?

‘A target on my back’: New survey shows racism is a hug...

In a new survey, 80% of nurses said they have seen or experienced racism from pa...

Opinion: Listen: Ezekiel Emanuel explains why cancer pa...

In the new episode of the "First Opinion Podcast," oncologist Ezekiel Emanuel ar...

Sacklers win appeal that shields them from opioid lawsu...

A federal appeals court ruled Tuesday Purdue Pharma can shield its owners from t...

Sen. Elizabeth Warren probes abortion access amid state...

Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on sta...

STAT+: Pharmalittle: Pfizer touts study data for hemoph...

A report by nonpartisan congressional researchers suggests there are at least so...

STAT+: European regulatory panel weighing against appro...

A European regulatory panel has taken a negative view of whether an ALS treatmen...

Opinion: More hospitals are offering child care. But th...

“Basically no one leaves that utilizes the child care center."

STAT+: Lured by a bigger payday, a medical device maker...

Lured by a bigger payday from insurance, a medical device maker sold fake plasti...

STAT wants to know your pick for a great summer read or...

We want to hear from you! We're gathering recommendations for books and podcasts...

Opinion: In defense of being ‘Cali sober’

Hardcore proponents of abstinence-based recovery, such as Alcoholics Anonymous, ...

STAT+: Just how vulnerable is Medicare drug negotiation...

A new report suggests there are at least some parts of the law setting up Medica...

Valneva seeks Health Canada approval for chikungunya va...

The single-shot vaccine is intended for persons aged 18 years and above.

Roche Canada and pCPA conclude talks for Vabysmo eye th...

Vabysmo helps treat neovascular (wet) age-related macular degeneration (AMD) and...

Sun Pharma and Philogen sign licence agreement for anti...

Sun Pharma will commercialise Nidlegy in three countries to treat skin cancers.